Oxipit, UAB

Oxipit manufactures AI-powered imaging analysis devices that assist radiologists in interpreting and processing medical images. These include CT Eye for computed tomography scans, ChestLink for chest imaging workflows, MSK Eye for musculoskeletal imaging, and ChestEye for chest radiography analysis. Each device is designed to enhance workflow efficiency and support diagnostic accuracy in specific imaging modalities.

Oxipit is based in Lithuania (LT). The company’s headquarters and operations are located within the country, though specific regional offices or manufacturing sites may vary. This location influences its regulatory compliance and participation in EU-based registries like eudamed.

Oxipit’s devices are listed in the eudamed database, which is the official EU registry for medical devices. Listing in eudamed is required for manufacturers to comply with EU Medical Device Regulations (MDR) and ensure transparency in the supply chain. This registry helps healthcare professionals, regulators, and authorities verify device details and traceability.

Oxipit’s devices are classified as Class IIa and Class IIb under EU Medical Device Regulations. The classification determines the level of scrutiny and regulatory requirements for each device. Class IIa devices pose a low-to-moderate risk, while Class IIb devices carry a higher risk, necessitating additional safety and performance evaluations before market placement.